A Phase I, Open-Label Study in Healthy Subjects, to Explore the Pharmacokinetics of Different Dosing Regimens of Rilpivirine in Combination With Rifabutin, at Steady-State
Latest Information Update: 15 Jul 2013
At a glance
- Drugs Rilpivirine (Primary) ; Rifabutin
- Indications HIV-1 infections; Mycobacterium avium complex infections
- Focus Pharmacokinetics
- 30 Jun 2013 Results presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
- 01 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jun 2012 New trial record